GO:0048006 antigen processing and presentation, endogenous lipid antigen via MHC class Ib: Lipid Antigen Presentation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048006 describes the process by which an antigen-presenting cell expresses endogenous lipid antigens in association with MHC class Ib molecules, primarily CD1 family proteins, on its surface.
• This pathway is distinct from classical MHC class I peptide presentation and is specialized for lipid and glycolipid antigens derived from the cell's own biosynthetic pathways.
• CD1a, CD1b, CD1c, and CD1d are the major MHC class Ib proteins involved, each with distinct lipid-binding grooves and trafficking routes.
• Endogenous lipid antigens presented via CD1 molecules can activate unconventional T cells such as NKT cells and gamma-delta T cells, linking lipid metabolism to immune surveillance.
• Dysregulation of this pathway is implicated in autoimmune diseases, cancer immune evasion, and infectious diseases where lipid antigens are key.
• CRISPR knockout, knock-in, and overexpression models of CD1 genes and lipid antigen processing enzymes enable functional dissection of this pathway in human cells.
Description
Antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006) is a specialized biological process in which antigen-presenting cells display lipid antigens of endogenous origin on their surface using non-classical MHC class I molecules, predominantly those of the CD1 family. Unlike classical MHC class I molecules that present peptide antigens to CD8+ T cells, MHC class Ib proteins such as CD1a, CD1b, CD1c, and CD1d have hydrophobic antigen-binding grooves adapted to accommodate lipids and glycolipids. This pathway is essential for immune recognition of lipid-based antigens that arise from cellular metabolism and membrane turnover. Researchers study this process to understand how the immune system monitors lipid homeostasis and how pathogens or tumors exploit lipid presentation to evade immunity. The pathway is particularly relevant in the context of autoimmune diseases, cancer immunology, and vaccine development targeting lipid antigens. Recent in silico evaluations of lung cancers with SMARCA4 genetic alterations have highlighted the importance of antigen presentation machinery, including MHC class Ib molecules, in shaping the immunogenic profile of tumors. This underscores the need for robust experimental models to dissect the molecular players in endogenous lipid antigen presentation.
antigen processing and presentation, endogenous lipid antigen via MHC class Ib At A Glance
| GO ID | GO:0048006 |
|---|---|
| GO term | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
| Ontology | biological_process |
| Synonym | antigen presentation, endogenous lipid antigen; endogenous lipid antigen processing and presentation via MHC class Ib |
| Major function | Presentation of endogenous lipid antigens to unconventional T cells via CD1 family proteins |
| Key molecules | CD1a, CD1b, CD1c, CD1d, beta-2-microglobulin, lipid transfer proteins |
| Cellular location | Endosomal compartments, lysosomes, plasma membrane |
| Associated cells | Dendritic cells, macrophages, B cells, thymocytes |
| Research relevance | Autoimmunity, cancer immunology, infectious disease, lipid metabolism |
What Is GO:0048006?
GO:0048006 is defined as the process in which an antigen-presenting cell expresses a lipid antigen of endogenous origin in association with an MHC class Ib protein complex on its cell surface. Here, MHC class Ib refers to non-classical class I molecules, such as those of the CD1 family, which present lipid-based antigens rather than peptides. The term encompasses the intracellular processing, loading, and surface presentation of endogenous lipids, distinguishing it from presentation of exogenous lipids or peptide antigens.
Why Is antigen processing and presentation, endogenous lipid antigen via MHC class Ib Important in Cell Biology?
Understanding GO:0048006 is critical because lipid antigens presented by MHC class Ib molecules serve as key signals for unconventional T cell subsets, including natural killer T (NKT) cells and germline-encoded mycolyl lipid-reactive (GEM) T cells, which bridge innate and adaptive immunity. This pathway enables immune surveillance of cellular lipid content and is exploited by pathogens such as Mycobacterium tuberculosis, which produces lipid antigens that can be presented via CD1b. In cancer, altered lipid metabolism and antigen presentation can influence tumor immunogenicity, as suggested by in silico analyses of SMARCA4-altered lung cancers. Moreover, defects in CD1-mediated lipid presentation are linked to autoimmune conditions and chronic inflammatory diseases. Thus, dissecting this process offers therapeutic opportunities for vaccines, immunotherapies, and diagnostics.
• Enables immune recognition of endogenous lipid antigens, expanding the repertoire beyond peptide presentation.
• Activates unconventional T cells such as NKT cells, gamma-delta T cells, and CD1-restricted T cells.
• Plays a role in host defense against lipid-rich pathogens like Mycobacterium tuberculosis.
• Contributes to immune tolerance and autoimmunity through lipid-specific T cell responses.
• Influences tumor immunogenicity and response to immunotherapy, as seen in SMARCA4-altered lung cancers.
• Links cellular lipid metabolism to immune surveillance and inflammation.
• Provides targets for vaccine adjuvants and lipid-based immunotherapies.
• Helps explain mechanisms of immune evasion by tumors and pathogens.
• Guides development of CRISPR models to study CD1 gene function.
• Supports biomarker discovery for diseases with dysregulated lipid presentation.
What Happens During antigen processing and presentation, endogenous lipid antigen via MHC class Ib?
Endogenous lipid antigen generation
In simple terms: The cell produces lipids that can become antigens.
Endogenous lipid antigens originate from cellular biosynthetic pathways, including membrane lipid turnover, cholesterol metabolism, and glycosphingolipid synthesis. These lipids are generated in the endoplasmic reticulum and Golgi apparatus, and some are transported to endosomal compartments where they can encounter CD1 molecules. The repertoire of endogenous lipids includes phospholipids, sphingolipids, and glycolipids that can be recognized by CD1-restricted T cells.
CD1 molecule synthesis and trafficking
In simple terms: CD1 proteins are made and moved to the right compartments to pick up lipids.
CD1a, CD1b, CD1c, and CD1d are synthesized in the endoplasmic reticulum and associate with beta-2-microglobulin. They traffic through the secretory pathway to the plasma membrane and are internalized into endosomal compartments. Different CD1 isoforms follow distinct intracellular routes: CD1a recycles through early endosomes, CD1b traffics to late endosomes and lysosomes, CD1c to early and late endosomes, and CD1d to late endosomes and lysosomes. This differential trafficking allows sampling of distinct lipid pools.
Lipid loading onto CD1 molecules
In simple terms: Lipids are inserted into the CD1 binding groove.
In endosomal compartments, CD1 molecules exchange lipids with the help of lipid transfer proteins such as saposins (e.g., saposin B) and GM2 activator protein. These proteins facilitate the extraction of lipids from membranes and their loading into the hydrophobic CD1 groove. The acidic pH of endosomes promotes lipid exchange and stabilizes the CD1-lipid complex. The loading process is selective and depends on the size and structure of the lipid antigen.
Surface presentation and T cell recognition
In simple terms: The lipid-loaded CD1 moves to the cell surface to show the antigen to T cells.
After loading, CD1-lipid complexes are transported to the plasma membrane via vesicular trafficking. On the surface, they are recognized by T cell receptors (TCRs) of CD1-restricted T cells, including NKT cells, which can rapidly produce cytokines. This interaction can lead to T cell activation, proliferation, and effector functions. The presentation of endogenous lipid antigens via MHC class Ib is thus a key mechanism for immune surveillance of lipid homeostasis.
Key Genes Involved in GO:0048006 antigen processing and presentation, endogenous lipid antigen via MHC class Ib
The following genes encode proteins that are central to endogenous lipid antigen processing and presentation via MHC class Ib, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD1A | Lipid antigen presentation to T cells | Skin inflammation, allergy, cancer immunology |
| CD1B | Presentation of mycobacterial and self-lipids | Tuberculosis, autoimmune diseases |
| CD1C | Presentation of glycolipids and phospholipids | Microbial immunity, autoimmunity |
| CD1D | Presentation of alpha-galactosylceramide and self-lipids | NKT cell activation, cancer, autoimmunity |
| B2M | Beta-2-microglobulin, CD1 light chain | MHC class I assembly, immune deficiency |
| PSAP | Saposin precursor, lipid transfer | Gaucher disease, lipid presentation |
| GM2A | GM2 ganglioside activator, lipid transfer | Tay-Sachs disease, lipid loading |
| AP3B1 | Adaptor protein complex 3, CD1 trafficking | Hermansky-Pudlak syndrome, endosomal sorting |
| AP1M1 | Adaptor protein complex 1, CD1 trafficking | Endosomal trafficking, immune disorders |
| LAMP1 | Lysosomal marker, CD1 loading compartment | Lysosomal function, antigen presentation |
| NPC1 | Cholesterol trafficking, lipid antigen availability | Niemann-Pick disease, lipid presentation |
| NPC2 | Cholesterol transfer, lipid antigen loading | Niemann-Pick disease, CD1 function |
| SMPD1 | Sphingomyelin phosphodiesterase, lipid metabolism | Niemann-Pick disease, lipid antigens |
| GBA | Glucocerebrosidase, glycolipid metabolism | Gaucher disease, CD1 presentation |
| UGCG | Glucosylceramide synthase, glycolipid synthesis | Lipid antigen generation, cancer |
| B3GALT4 | Ganglioside biosynthesis | Lipid antigen diversity, neuroimmunology |
| ST3GAL5 | Ganglioside biosynthesis | Lipid antigen presentation, neurodevelopment |
How Is antigen processing and presentation, endogenous lipid antigen via MHC class Ib Regulated?
The process of endogenous lipid antigen presentation via MHC class Ib is regulated at multiple levels, including transcriptional control of CD1 genes, post-translational modification of CD1 molecules, and the availability of lipid antigens. Cytokines such as GM-CSF and IL-4 can upregulate CD1 expression on dendritic cells, enhancing lipid presentation. Lipid metabolism pathways, including those controlled by transcription factors like SREBP and PPAR, influence the pool of endogenous lipids available for loading. Additionally, endosomal pH and lipid transfer proteins such as saposins regulate the exchange of lipids onto CD1 molecules. In cancer, genetic alterations such as SMARCA4 mutations may impact antigen presentation machinery, as suggested by in silico analyses. However, the precise regulatory networks remain an active area of research.
antigen processing and presentation, endogenous lipid antigen via MHC class Ib and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD1A | Skin inflammation, allergy | Knockout human keratinocytes, overexpression in dendritic cells |
| CD1B | Tuberculosis, autoimmune diseases | Knockout macrophages, point mutation in lipid-binding groove |
| CD1D | NKT cell-mediated autoimmunity, cancer | Knockout mice, human cell lines with CD1D knockout |
| PSAP | Gaucher disease, lipid presentation defects | Knockout iPSC-derived macrophages, knock-in of disease mutations |
| NPC1 | Niemann-Pick disease, lipid trafficking | Knockout hepatocytes, overexpression of mutant NPC1 |
Cancer immunology and immune evasion
Alterations in antigen presentation pathways, including MHC class Ib-mediated lipid presentation, can affect tumor immunogenicity. In silico evaluation of lung cancers with SMARCA4 genetic alterations revealed potential changes in immunogenic profiles, highlighting the relevance of antigen presentation machinery in cancer. Tumors may downregulate CD1 molecules or alter lipid metabolism to evade CD1-restricted T cell responses. Understanding these mechanisms could inform immunotherapeutic strategies.
Autoimmune and inflammatory diseases
CD1-restricted T cells that recognize endogenous lipids can contribute to autoimmune pathology. For example, CD1d-restricted NKT cells are implicated in type 1 diabetes, multiple sclerosis, and inflammatory bowel disease. Dysregulated lipid presentation may lead to aberrant T cell activation and tissue damage. Targeting this pathway is being explored for therapeutic intervention.
Infectious diseases
Pathogens such as Mycobacterium tuberculosis produce lipid antigens that are presented via CD1b to T cells. This pathway is critical for host defense against tuberculosis, and its manipulation by pathogens can lead to immune evasion. Other pathogens, including fungi and parasites, also modulate lipid presentation. Studying these interactions can guide vaccine development.
From antigen processing and presentation, endogenous lipid antigen via MHC class Ib-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD1A loss affect lipid antigen presentation? | CD1A knockout in human dendritic cell line |
| How do point mutations in CD1B alter lipid binding? | CD1B point-mutation knock-in in HEK293T cells |
| Can overexpression of CD1D enhance NKT cell activation? | CD1D overexpression in antigen-presenting cells |
| What is the role of saposin B in lipid loading? | PSAP knockout in macrophages |
| How does SMARCA4 alteration impact antigen presentation? | SMARCA4 knockout in lung cancer cell lines |
| Can tagged CD1c be used to track trafficking? | CD1C tagged knock-in in primary dendritic cells |
How to Study the antigen processing and presentation, endogenous lipid antigen via MHC class Ib Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for lipid presentation | Identify novel regulators |
| Flow cytometry | CD1 surface expression, T cell activation | Quantify presentation efficiency |
| Lipidomics | Endogenous lipid antigen repertoire | Profile loaded lipids |
| Proteomics | CD1 interactome | Discover trafficking partners |
| Live-cell imaging | CD1 endosomal trafficking | Visualize loading compartments |
| Tetramer staining | Antigen-specific T cells | Detect CD1-restricted T cells |
| RNA-seq | Transcriptional changes in CD1 genes | Assess regulation of expression |
CRISPR screening for lipid presentation regulators
Genome-wide CRISPR knockout screens can identify genes required for endogenous lipid antigen presentation via MHC class Ib. Cells expressing CD1 molecules and a reporter for T cell activation can be used to select for loss or gain of presentation. This approach has uncovered novel regulators of lipid metabolism and endosomal trafficking.
Flow cytometry and tetramer staining
Flow cytometry with CD1-lipid tetramers allows detection of antigen-specific T cells and quantification of CD1 surface expression. This method is essential for assessing presentation efficiency and T cell responses. It can be combined with intracellular cytokine staining to measure functional outcomes.
Proteomics and lipidomics
Mass spectrometry-based lipidomics can profile the endogenous lipid antigens loaded onto CD1 molecules. Proteomics of CD1-associated proteins can reveal interaction partners and trafficking machinery. These techniques provide a systems-level view of the pathway.
Imaging of CD1 trafficking
Live-cell imaging with fluorescently tagged CD1 molecules enables visualization of endosomal trafficking and lipid loading. Confocal microscopy can track co-localization with lipid transfer proteins and lysosomal markers. This helps define the spatiotemporal dynamics of presentation.
How CRISPR Can Be Used to Study GO:0048006 antigen processing and presentation, endogenous lipid antigen via MHC class Ib
Knockout
CRISPR knockout of CD1 genes or lipid transfer proteins (e.g., PSAP, GM2A) in human cell lines or primary cells abolishes endogenous lipid antigen presentation. This allows researchers to test the requirement of specific genes for T cell activation. Knockout models are also used to identify compensatory pathways.
Point Mutation
Introducing point mutations in the lipid-binding groove of CD1 molecules (e.g., CD1B) via CRISPR knock-in can dissect the structural requirements for lipid antigen recognition. Such models help distinguish between presentation of different lipid classes. They are valuable for understanding autoimmune-associated CD1 variants.
Knock-in
Knock-in of tagged CD1 molecules (e.g., GFP-CD1c) enables tracking of trafficking and loading in live cells. Knock-in of disease-associated mutations (e.g., in NPC1) can model lipid presentation defects. This approach provides physiological expression levels and context.
Overexpression
Overexpression of CD1 molecules or lipid antigens can enhance presentation and amplify T cell responses. This is useful for studying downstream signaling and for vaccine development. Overexpression models can also reveal dominant-negative effects.
How EDITGENE Supports antigen processing and presentation, endogenous lipid antigen via MHC class Ib Research
Researchers studying antigen processing and presentation, endogenous lipid antigen via MHC class Ib-related genes often need to determine whether a candidate gene is causally involved in lipid antigen presentation, T cell activation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for antigen processing and presentation, endogenous lipid antigen via MHC class Ib research.
Frequently Asked Questions About antigen processing and presentation, endogenous lipid antigen via MHC class Ib
What is GO:0048006?
GO:0048006 is a Gene Ontology term for the biological process of antigen processing and presentation of endogenous lipid antigens via MHC class Ib molecules, such as CD1 proteins.
What genes are involved in endogenous lipid antigen presentation via MHC class Ib?
Key genes include CD1A, CD1B, CD1C, CD1D, B2M, PSAP, GM2A, and various lipid metabolism genes like NPC1 and GBA.
How does CD1d present endogenous lipids?
CD1d traffics to late endosomes/lysosomes where it exchanges lipids with the help of saposins, then moves to the cell surface to present lipid antigens to NKT cells.
What diseases are associated with defects in lipid antigen presentation?
Diseases include autoimmune conditions, cancer immune evasion, and infectious diseases such as tuberculosis.
Can CRISPR be used to study lipid antigen presentation?
Yes, CRISPR knockout, knock-in, and overexpression models of CD1 genes and related factors are powerful tools to dissect this pathway.
What is the role of SMARCA4 in antigen presentation?
In silico studies suggest that SMARCA4 genetic alterations may impact the immunogenic profile of lung cancers, potentially affecting antigen presentation machinery.
Which T cells recognize CD1-lipid complexes?
NKT cells, gamma-delta T cells, and other CD1-restricted T cells recognize lipid antigens presented by CD1 molecules.
How is endogenous lipid antigen different from exogenous?
Endogenous lipid antigens are derived from the cell's own metabolism, while exogenous lipids come from outside the cell.
What are MHC class Ib molecules?
MHC class Ib molecules are non-classical MHC class I proteins, including CD1 family members, that present lipid antigens rather than peptides.
What experimental models are used to study GO:0048006?
Common models include CRISPR knockout cell lines, knock-in mice, and human primary cell cultures, combined with flow cytometry and lipidomics.
Conclusion
GO:0048006 represents a vital immune surveillance mechanism for endogenous lipid antigens, mediated by MHC class Ib molecules such as CD1 proteins. This pathway is integral to host defense, autoimmunity, and cancer immunology, and its dysregulation contributes to various diseases. Advances in CRISPR gene editing and functional genomics are accelerating the discovery of new players and therapeutic targets in this pathway. Continued research will deepen our understanding of lipid antigen presentation and its translational potential.
References
- 1. Nieto-Jiménez C et al.. 2025. In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations.. Sci Rep 15(1):17832 PMID: 40404793
